Share chart Insulet Corporation
Extended chart
Simple chart
About Insulet Corporation
Корпорация Insulet разрабатывает, производит и продает системы доставки инсулина для людей с инсулинозависимым диабетом. Он предлагает систему Omnipod, самоклеящееся одноразовое бескамерное устройство Omnipod, которое носится на теле до трех дней одновременно, а также беспроводной компаньон, портативный персональный менеджер диабета. Компания продает свою продукцию в основном через независимых дистрибьюторов и аптечные каналы, а также непосредственно в Соединенных Штатах, Канаде, Европе и на Ближнем Востоке. Корпорация Insulet была основана в 2000 году со штаб-квартирой в Актоне, штат Массачусетс.Main settings
IPO date
2007-05-15
ISIN
US45784P1012
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Grade
Underestimation
Title | Value | Grade |
P/S | 9.39 | 1 |
P/BV | 16.06 | 1 |
P/E | 46.52 | 3 |
Efficiency
Title | Value | Grade |
ROA | 14.74 | 4 |
ROE | 43.03 | 10 |
ROIC | 5.25 | 2 |
Dividends
Title | Value | Grade |
Dividend yield | 0 | 0 |
DSI | 0 | 0 |
Average dividend growth | 0 | 0 |
Debt
Title | Value | Grade |
Debt/EBITDA | 3.29 | 4 |
Debt/Ratio | 0.4509 | 10 |
Debt/Equity | 1.55 | 7 |
Growth impulse
Title | Value | Grade |
Yield Revenue, % | 129.16 | 10 |
Yield Ebitda, % | 285.18 | 10 |
Yield EPS, % | 5561.12 | 10 |
Prices
Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
Yesterday | 301.62 $ | 0 $ | 0 $ | -0.189 % | 0 % | 0 % |
Week | 309.83 $ | 0 $ | 0 $ | -2.83 % | 0 % | 0 % |
Month | 319.21 $ | 299.99 $ | 314.18 $ | -5.69 % | 0 % | 0 % |
Three month | 244.02 $ | 250.25 $ | 327.47 $ | +23.37 % | 0 % | 0 % |
Half a year | 280.56 $ | 237.06 $ | 327.47 $ | +7.3 % | 0 % | 0 % |
Year | 233.87 $ | 180.69 $ | 327.47 $ | +28.73 % | 0 % | 0 % |
3 years | 234.19 $ | 130.7 $ | 330.23 $ | +28.55 % | 0 % | 0 % |
5 years | 225.02 $ | 130.7 $ | 330.23 $ | +33.79 % | 0 % | 0 % |
10 years | 24.68 $ | 24.68 $ | 330.23 $ | +1 246.41 % | 0 % | 0 % |
Year to date | 278.38 $ | 237.06 $ | 327.47 $ | +8.14 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
Global X Telemedicine & Digital Health ETF Registered | 5.20363 | 0.4251 | 0.68 |
Harbor Disruptive Innovation ETF | 0.5779 | 14.07 | 0.75 |
Fidelity Growth Opportunities ETF | 0.38428 | -10.26 | 0.38 |
iShares Morningstar Mid-Cap Growth ETF | 0.30698 | 450.65 | 0.06 |
iShares Morningstar Mid-Cap ETF | 0.15338 | 245.03 | 0.04 |
iShares Morningstar Large-Cap Growth ETF | 0.06781 | 245.22 | 0.04 |
Columbia U.S. ESG Equity Income ETF | 0.0575 | -4.51 | 0.35 |
iShares Factors US Growth Style ETF | 0.04785 | -6.31 | 0.25 |
iShares Morningstar Large-Cap ETF | 0.03237 | 186.3 | 0.03 |
0.76 | 124.51 | 0.29 |
---|
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
Ms. Lauren Budden | Group VP, Chief Accounting Officer & Controller | N/A | 1975 (50 years) |
Ms. Deborah R. Gordon CPA | Vice President of Investor Relations | N/A | 1971 (54 years) |
Mr. John Wodick Kapples | Senior VP & General Counsel | 783.36k | 1960 (65 years) |
Dr. James R. Hollingshead Ph.D. | President, CEO & Director | 2.18M | 1963 (62 years) |
Mr. Prem Singh | Senior Vice President of Global Operations | N/A | 1977 (48 years) |
Ms. Laetitia Cousin | Senior VP of Regulatory Affairs, Quality Assurance & Compliance | N/A | 1976 (49 years) |
Mr. Eric Benjamin | Executive VP, Chief Product & Customer Experience Officer | 947.57k | 1983 (42 years) |
Mr. Mark Field | Senior VP & CTO | N/A | 1971 (54 years) |
Angela Geryak Wiczek | Senior Director of Corporate Communications | N/A | |
Ms. Ana Maria Chadwick | Executive VP, CFO & Treasurer | 1972 (53 years) |
About company
Address: United States, Acton, 100 Nagog Park - Open in google maps, Open in yandex maps
Website: http://www.insulet.com
Website: http://www.insulet.com